Today, physicians are using stem cell therapies in the treatment of a wide variety of medical diseases/disorders and traumas.  Presently, the use of stem cells is becoming common practice with orthopedics as it may help deter a knee replacement or surgical procedure and improve function of joints following injury. Practitioners today are also using stem cells within disciplines such as pain management, cardiology, rheumatology, and neurology.

To see more research studies related to stem cell use, click here.


Cartilage and joint function improvement
In the area of joint injury and degeneration, mesenchymal (MSC) stem cells are being used to improve the function of joints. There are greater than 20 clinical studies or case studies in the peer-reviewed scientific literature all demonstrating that stem cells may regenerate tissue, improve function, reduce pain and improve the quality of life for those suffering from orthopedic problems. 

Fracture repair

Stem cell therapies have shown to be highly successful in the treatment of bone fractures. One review reports injections of stem cells achieving 75% union over 14 weeks in one case, and 88% union over four months in another in patients with non-union bone fractures.

Treatment of Arthritis

Regenerative medicine therapies utilize the anti-inflammatory properties of stem cells to alleviate inflammation-related osteoarthritis (OA) pain. In a 2011 study, for example, patients with severe OA were injected with mesenchymal stem cells and found they were able to walk longer without pain and climb a greater number of stairs after treatment. A follow-up study five years later showed that improvements had decreased, but that the knee that had received stem cell treatment was still better than at baseline. There are many other studies similar to this all supporting the notion that stem cells may be beneficial in treating arthritic conditions.

Treatment of Heart Disease 

Therapies for victims of cardiovascular disease (coronary heart disease, hypertension, stroke, and congestive heart failure) now include the use of stem cells. Scientists have been able to culture MSCs to differentiate into cells resembling cardiomyocytes, the tissues lost when cardiac tissues are deprived of oxygen. So stem cell treatment may actually rebuild and replace damaged heart muscle tissue. In addition, clinical studies in cardiovascular disease have shown promise. In a 2012 study on treatments for ischemic cardiomyopathy (ICM), patients who received stem cell therapy reported increased functional capacity and improved quality of life. 

Treatment of Autoimmune Disorders

Stem cell therapy could be an excellent, minimally-invasive treatment option for patients with lupus, rheumatoid arthritis, multiple sclerosis, and other autoimmune diseases. MSCs may help drive the patient's immune system toward a more favorable TH1/TH2 balance, as well as increase the number of Treg cells. This has been clearly documented in clinical studies on over 100 patients with lupus and rheumatoid arthritis receiving umbilical cord MSCs.
The treatments aim to strategically remove problematic immune cells, and restore functional immune cells to the body. In one clinical trial of lupus patients, patients treated with MSCs experienced stable disease remission for 12 to 18 months.

Treatment of Parkinson’s Disease

Research is finding that stem cells found in bone marrow can be differentiated into cells to treat Parkinson’s disease. With Parkinson’s, the brain produces less and less dopamine over time, and the person loses the ability to control body movements. Recently, treatments using bone-marrow MSCs to differentiate into dopamine secretory cells have shown encouraging results: almost half of the patients in a Parkinson’s treatment study showed steady improvement over 10-36 months.  

Why Choose Stem Cells From Liveyon?

Liveyon provides physicians with a product that comes from a reliable source, and our stem cells are carefully controlled by regulated, independent testing.   Learn more about our product.

Today’s patients are becoming more interested in alternative and minimally-invasive treatments, and are more educated with regards to their conditions. Offering stem cell therapy with Liveyon’s stem cells at your practice provides opportunities for growth, and a way to offer your patients more options.

Contact us online or call us at 844-LIVEYON to learn more.

Translate »


Medical Professional Viewing Only (Disclaimer)

This site was intended for education purposes only and strictly for use by medical professionals. The FDA recently re-confirmed, there is only one registered stem cell product, and while there is enormous promise in stem cell therapies, and thousands of ongoing experimental applications trying to establish efficacy, these are not at the point where they would meet the scientific standard.
The FDA has stated:
Stem cells, like other medical products that are intended to treat, cure or prevent disease, generally require FDA approval before they can be marketed. FDA has not approved any stem cell-based products for use, other than cord blood-derived hematopoietic progenitor cells (blood forming stem cells) for certain indications.
This site is not intended for consumers.
If you are considering stem cell treatment in the U.S., ask your physician if the necessary FDA approval has been obtained or if you will be part of an FDA-regulated clinical study. This also applies if the stem cells are your own. Even if the cells are yours, there are safety risks, including risks introduced when the cells are manipulated after removal.
“There is a potential safety risk when you put cells in an area where they are not performing the same biological function as they were when in their original location in the body.” Cells in a different environment may multiply, form tumors, or may leave the site you put them in and migrate somewhere else.
If you are considering having stem cell treatment in another country, learn all you can about regulations covering the products in that country. Exercise caution before undergoing treatment with a stem cell-based product in a country that—unlike the U.S.—may not require clinical studies designed to demonstrate that the product is safe and effective. FDA does not regulate stem cell treatments used solely in countries other than the United States and typically has little information about foreign establishments or their stem cell products.
Stem cell therapies have enormous promise, but the science in each use is still in the developmental stage. Professional judgment and expertise is needed in using stem cells for any therapeutic use, and we urge anyone embarking on the use of stem cell therapies to consult the national health data bases to evaluate current information from clinical trials and the FDA websites on human tissue should also be consulted to get its current evaluation of any therapy.